Prophylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirus
- Journal Article
Journal / seriesProceedings of the National Academy of Sciences of the United States of America
Pages / Article No.
PublisherNational Academy of Sciences
SubjectMERS-CoV; Neutralizing antibody; Serotherapy; Emerging viruses
Organisational unit03856 - Lanzavecchia, Antonio (emeritus)
NotesReceived for review 25 May 2015, Approved 29 June 2015.
MoreShow all metadata